No Data
No Data
No Data
No Data
No Data
Are Investors Undervaluing Core Laboratories Inc. (NYSE:CLB) By 35%?
Key Insights Core Laboratories' estimated fair value is US$24.29 based on 2 Stage Free Cash Flow to Equity Current share price of US$15.80 suggests Core Laboratories is potentially 35% undervalued
Simply Wall StMay 1 20:07
These Return Metrics Don't Make Core Laboratories (NYSE:CLB) Look Too Strong
Yahoo FinanceApr 30 02:59
Core Labs Is Maintained at Hold by Stifel
Core Labs Is Maintained at Hold by Stifel
Dow JonesApr 26 23:28
Stifel: Maintaining the Core Laboratories (CLB.US) rating, adjusted from holding to holding rating, and adjusting the target price from $17.00 to $18.00.
Stifel: Maintaining the Core Laboratories (CLB.US) rating, adjusted from holding to holding rating, and adjusting the target price from $17.00 to $18.00.
Zhitong FinanceApr 26 23:20
Stifel Maintains Hold on Core Laboratories, Raises Price Target to $18
Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and raises the price target from $17 to $18.
BenzingaApr 26 23:18
Stifel Nicolaus Sticks to Its Hold Rating for Core Laboratories (CLB)
TipRanksApr 26 19:55
No Data
No Data